128615-83-8

Basic information

• Product Name: Phthalazine, 1-chloro-4-(4-methoxyphenyl)-
• Synonyms: 1-chloro-4-(4-methoxyphenyl)-phthalazine;1-chloro-4-(4-methoxy-phenyl)-phthalazine;1-Chlor-4-(4-methoxy-phenyl)-phthalazin
• CAS NO: 128615-83-8
• Molecular Formula: C15H11ClN2O
• Molecular Weight: 270.718
• Mol File: 128615-83-8.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Phthalazine, 1-chloro-4-(4-methoxyphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Phthalazine, 1-chloro-4-(4-methoxyphenyl)-(128615-83-8)
• EPA Substance Registry System: Phthalazine, 1-chloro-4-(4-methoxyphenyl)-(128615-83-8)

Safety Data

• Hazardous Substances Data: 128615-83-8(Hazardous Substances Data)

Usage

General Description

Phthalazine, 1-chloro-4-(4-methoxyphenyl)- is a chemical compound with the molecular formula C14H10ClNO. It is a phthalazine compound with a chlorine atom at the 1-position and a 4-(4-methoxyphenyl) group at the 4-position. This chemical is used in organic synthesis and pharmaceutical research and has potential applications as an intermediate for the synthesis of various biologically active compounds. The 1-chloro-4-(4-methoxyphenyl)-phthalazine may have properties and uses that are currently under research and exploration.

Upstream product

• 57353-93-2 4-(4-methoxyphenyl)-1,2-dihydrophthalazin-1-one 
• 1151-15-1 2-(4-methoxybenzoyl)benzoic acid 
• 4752-10-7 1,4-dichlorophthalazine 
• 270262-18-5 4-methoxyphenyl boric acid 

Downstream Products

• 120116-67-8 4-(4'-methoxyphenyl)-1-hydrazinophthalazine 
• 5021-58-9 5-(4-methoxy-phenyl)-phthalazino[1,2-b]quinazolin-8-one 
• 155937-30-7 1-(4-Methoxy-phenyl)-4-phenoxy-phthalazine 
• 1071584-40-1 4-(4-(4-methoxyphenyl)phthalazin-1-ylamino)phenol hydrochloride 
• 126229-03-6 3-phenyl-6-(4'-methoxyphenyl)-1,2,4-triazolo<3,4-a>phthalazine 
• 126008-97-7 3-(3,4-Dimethoxy-phenyl)-6-(4-methoxy-phenyl)-[1,2,4]triazolo[3,4-a]phthalazine 
• 126008-90-0 N-[4-(4-Methoxy-phenyl)-phthalazin-1-yl]-N'-[1-(2-nitro-phenyl)-meth-(Z)-ylidene]-hydrazine 
• 126008-88-6 N-[1-(3,4-Dimethoxy-phenyl)-meth-(Z)-ylidene]-N'-[4-(4-methoxy-phenyl)-phthalazin-1-yl]-hydrazine 
• 126008-99-9 6-(4-Methoxy-phenyl)-3-(2-nitro-phenyl)-[1,2,4]triazolo[3,4-a]phthalazine 
• 126008-87-5 N-[1-(4-Methoxy-phenyl)-meth-(Z)-ylidene]-N'-[4-(4-methoxy-phenyl)-phthalazin-1-yl]-hydrazine 
• 126008-96-6 3,6-Bis-(4-methoxy-phenyl)-[1,2,4]triazolo[3,4-a]phthalazine 
• 126008-98-8 6-(4-Methoxy-phenyl)-3-p-tolyl-[1,2,4]triazolo[3,4-a]phthalazine 
• 126008-89-7 N-[4-(4-Methoxy-phenyl)-phthalazin-1-yl]-N'-[1-p-tolyl-meth-(Z)-ylidene]-hydrazine 
• 126008-86-4 N-[4-(4-Methoxy-phenyl)-phthalazin-1-yl]-N'-[1-phenyl-meth-(Z)-ylidene]-hydrazine 

Relevant articles and documents

NITROGENOUS FUSED HETEROAROMATIC RING DERIVATIVE

The invention provides a compound or its pharmaceutically-acceptable salt of formula (I): wherein A1 is a hydrogen, etc.; j and k are 0 or 1; is a double bond, etc.; is a double bond, etc.; one of W1 and W2 is E-O-W, etc., and the other is a hydrogen atom, etc.; E is a divalent group derived from a benzene ring, etc., by removing two hydrogen atoms therefrom; W is a group of formula (II-1): which has a histamine-H3 receptor antagonistic effect or a histamine-H3 receptor inverse-agonistic effect and is useful for prevention or remedy of metabolic system diseases, circulatory system diseases or nervous system diseases.

Condensed pyridazinyl guanidines, their production and use

Pyridazinyl guanidines of the formula: wherein ring A is a benzene ring or a nitrogen-containing 6-membered aromatic ring, each of which may be substituted; and R1is an aromatic ring group which may be substituted, or a salt thereof, which have activity for inhibiting Na-H exchange and are useful as a prophylactic/therapeutic agent for ischemic cardiovascular diseases such as myocardial infarction and arrythmia.